Survivors of pediatric retinoblastoma have few cognitive and social problems during adulthood
the ONA take:
According to a new study published online in the journal Cancer, researchers have found that adults who survived childhood retinoblastoma have limited cognitive and social issues later in life.
For the study, researchers at St. Jude Children's Research Hospital in Memphis, Tennessee, sought to investigate the long-term health issues of survivors of the eye cancer following diagnosis and treatment. Although most children are cured of the disease, survivors have a higher risk of long-term health effects from intensive treatments.
The researchers identified 69 adult survivors of childhood retinoblastoma who were 33 years old on average and were treated for the treated an average of 31 years earlier. Participants then completed cognitive evaluations and questionnaires.
Results showed that survivors had few cognitive and social problems. In addition, researchers found that patients who received whole brain radiation treatment had a poorer performance on short-term and long-term verbal memory tasks.
They also found that survivors who were diagnosed before age 1 had a significantly better performance on short-term and long-term verbal memory tasks, verbal learning tasks, and verbal reasoning measures compared with those diagnosed after age 1. The researchers suggest that the brain is able to adapt and reorganize following early treatment.
Adults who survived childhood retinoblastoma have limited cognitive and social issues later in life.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|